Aethlon Medical Inc reports results for the quarter ended in March - Earnings Summary

Aethlon Medical

27/06/2024 22:36

* Aethlon Medical Inc  AEMD.OQ  reported a quarterly
adjusted loss
of 91 cents​​ per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of $-1.00.  The mean expectation of three analysts for the
quarter was for a loss of $1.23 per share. Wall Street expected
results to range from $-1.41 to $-1.10 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 91 cents​.
    * The company reported a quarterly loss of $2.43 million.
    * Aethlon Medical Inc shares had fallen by 65.2% this
quarter and
lost 73.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is  "hold."

Wall Street's median 12-month price target for Aethlon Medical
Inc is $5.25 
This summary was machine generated from LSEG data June 27 at
09:35 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.23          -0.91          Beat
 Dec. 31 2023      -1.23          -1.37          Missed
 Sep. 30 2023      -1.40          -1.22          Beat
 Jun. 30 2023      -1.30          -1.40          Missed